218 related articles for article (PubMed ID: 24616589)
1. Relationship between tetrahydrobiopterin and portal hypertension in patients with chronic liver disease.
Hong WK; Shim KY; Baik SK; Kim MY; Cho MY; Jang YO; Park YS; Han J; Kim G; Cho YZ; Hwang HW; Lee JH; Chae MH; Kwon SO
J Korean Med Sci; 2014 Mar; 29(3):392-9. PubMed ID: 24616589
[TBL] [Abstract][Full Text] [Related]
2. 5-MTHF enhances the portal pressure reduction achieved with propranolol in patients with cirrhosis: A randomized placebo-controlled trial.
Vukotic R; Di Donato R; Roncarati G; Simoni P; Renzulli M; Gitto S; Schepis F; Villa E; Berzigotti A; Bosch J; Andreone P
J Hepatol; 2023 Oct; 79(4):977-988. PubMed ID: 37482222
[TBL] [Abstract][Full Text] [Related]
3. Effects of Sapropterin on Portal and Systemic Hemodynamics in Patients With Cirrhosis and Portal Hypertension: A Bicentric Double-Blind Placebo-Controlled Study.
Reverter E; Mesonero F; Seijo S; Martínez J; Abraldes JG; Peñas B; Berzigotti A; Deulofeu R; Bosch J; Albillos A; García-Pagán JC
Am J Gastroenterol; 2015 Jul; 110(7):985-92. PubMed ID: 26077176
[TBL] [Abstract][Full Text] [Related]
4. Patients With Signs of Advanced Liver Disease and Clinically Significant Portal Hypertension Do Not Necessarily Have Cirrhosis.
Rodrigues SG; Montani M; Guixé-Muntet S; De Gottardi A; Berzigotti A; Bosch J
Clin Gastroenterol Hepatol; 2019 Sep; 17(10):2101-2109.e1. PubMed ID: 30625404
[TBL] [Abstract][Full Text] [Related]
5. Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study.
Robic MA; Procopet B; Métivier S; Péron JM; Selves J; Vinel JP; Bureau C
J Hepatol; 2011 Nov; 55(5):1017-24. PubMed ID: 21354450
[TBL] [Abstract][Full Text] [Related]
6. Non-invasive aspartate aminotransferase to platelet ratio index correlates well with invasive hepatic venous pressure gradient in cirrhosis.
Kirnake V; Arora A; Sharma P; Goyal M; Chawlani R; Toshniwal J; Kumar A
Indian J Gastroenterol; 2018 Jul; 37(4):335-341. PubMed ID: 30178093
[TBL] [Abstract][Full Text] [Related]
7. The impact of hepatic steatosis on portal hypertension.
Semmler G; Scheiner B; Schwabl P; Bucsics T; Paternostro R; Chromy D; Stättermayer AF; Trauner M; Mandorfer M; Ferlitsch A; Reiberger T
PLoS One; 2019; 14(11):e0224506. PubMed ID: 31693695
[TBL] [Abstract][Full Text] [Related]
8. Novel imaging-based approaches for predicting the hepatic venous pressure gradient in a porcine model of liver cirrhosis and portal hypertension.
Ma Y; Dong D; Gong Z; Yan B; Guo Q
Life Sci; 2021 Jan; 264():118710. PubMed ID: 33144188
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of 833 times measured hepatic venous pressure gradient].
Zhang MY; Wang GC; Huang GJ; Feng H; Wang LF; Zhang JY; Shi YJ; Zhang CQ
Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):266-270. PubMed ID: 29996337
[No Abstract] [Full Text] [Related]
10. Hepatic venous pressure gradient: clinical use in chronic liver disease.
Suk KT
Clin Mol Hepatol; 2014 Mar; 20(1):6-14. PubMed ID: 24757653
[TBL] [Abstract][Full Text] [Related]
11. Histological subclassification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertension.
Kim MY; Cho MY; Baik SK; Park HJ; Jeon HK; Im CK; Won CS; Kim JW; Kim HS; Kwon SO; Eom MS; Cha SH; Kim YJ; Chang SJ; Lee SS
J Hepatol; 2011 Nov; 55(5):1004-9. PubMed ID: 21354227
[TBL] [Abstract][Full Text] [Related]
12. Portal hypertension in patients with cirrhosis: indirect assessment of hepatic venous pressure gradient by measuring azygos flow with 2D-cine phase-contrast magnetic resonance imaging.
Gouya H; Grabar S; Vignaux O; Saade A; Pol S; Legmann P; Sogni P
Eur Radiol; 2016 Jul; 26(7):1981-90. PubMed ID: 26373753
[TBL] [Abstract][Full Text] [Related]
13. Hepatic Venous Pressure Gradient Measurements in Children: Correlation With Hepatic Histology and Clinical Indicators of Portal Hypertension.
Ebel NH; Carlin K; Shaffer ML; Shivaram G; Hawkins M; Lane ER; Cooper K; Lindquester WS; Gadodia G; Murray KF
J Pediatr Gastroenterol Nutr; 2019 Jun; 68(6):788-792. PubMed ID: 30921261
[TBL] [Abstract][Full Text] [Related]
14. The usefulness of non-invasive liver stiffness measurements in predicting clinically significant portal hypertension in cirrhotic patients: Korean data.
Hong WK; Kim MY; Baik SK; Shin SY; Kim JM; Kang YS; Lim YL; Kim YJ; Cho YZ; Hwang HW; Lee JH; Chae MH; Kim HA; Kang HW; Kwon SO
Clin Mol Hepatol; 2013 Dec; 19(4):370-5. PubMed ID: 24459641
[TBL] [Abstract][Full Text] [Related]
15. Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis.
Lemoine M; Katsahian S; Ziol M; Nahon P; Ganne-Carrie N; Kazemi F; Grando-Lemaire V; Trinchet JC; Beaugrand M
Aliment Pharmacol Ther; 2008 Nov; 28(9):1102-10. PubMed ID: 18691352
[TBL] [Abstract][Full Text] [Related]
16. Plasma Nogo-A and placental growth factor levels are associated with portal hypertension in patients with liver cirrhosis.
Gelman S; Salteniene V; Pranculis A; Skieceviciene J; Zykus R; Petrauskas D; Kupcinskas L; Canbay A; Link A; Kupcinskas J
World J Gastroenterol; 2019 Jun; 25(23):2935-2946. PubMed ID: 31249451
[TBL] [Abstract][Full Text] [Related]
17. Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension.
Garcia-Tsao G; Bosch J; Kayali Z; Harrison SA; Abdelmalek MF; Lawitz E; Satapathy SK; Ghabril M; Shiffman ML; Younes ZH; Thuluvath PJ; Berzigotti A; Albillos A; Robinson JM; Hagerty DT; Chan JL; Sanyal AJ;
J Hepatol; 2020 May; 72(5):885-895. PubMed ID: 31870950
[TBL] [Abstract][Full Text] [Related]
18. A computational model of the hepatic circulation applied to analyze the sensitivity of hepatic venous pressure gradient (HVPG) in liver cirrhosis.
Wang T; Liang F; Zhou Z; Shi L
J Biomech; 2017 Dec; 65():23-31. PubMed ID: 29042056
[TBL] [Abstract][Full Text] [Related]
19. Hepatic venous pressure gradient evaluates the Scheuer stage of liver fibrosis by transjugular liver biopsy: a multicenter study.
Zhang H; Wang Z; Wei X; Wu H; Li L; Guo W; Li L; Wang R; Yang C; Yan X; Wang F; Yan J; Li X
HPB (Oxford); 2023 Jun; 25(6):644-649. PubMed ID: 36878751
[TBL] [Abstract][Full Text] [Related]
20. Portal hypertension is the main driver of liver stiffness in advanced liver cirrhosis.
Lunova M; Frankova S; Gottfriedova H; Senkerikova R; Neroldova M; Kovac J; Kieslichova E; Lanska V; Sticova E; Spicak J; Jirsa M; Sperl J
Physiol Res; 2021 Aug; 70(4):563-577. PubMed ID: 34062072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
